C07C 2603/98
Containing at least one ring with more than six ring members
Official title: containing at least one ring with more than six ring members
C07C2603/98 (Containing at least one ring with more than six ring members) appears on 25 US grants and 38 published applications in this corpus.
Search patents in C07C- Granted patents
- 25
- Published applications
- 38
- Assignees
- 20
- Inventors
- 61
- Latest grant
- 12 Dec 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 2 | 3 |
| 2011 | 2 | 0 |
| 2012 | 1 | 1 |
| 2013 | 1 | 3 |
| 2014 | 1 | 1 |
| 2015 | 1 | 2 |
| 2016 | 2 | 1 |
| 2017 | 3 | 8 |
| 2018 | 1 | 2 |
| 2019 | 4 | 1 |
| 2020 | 1 | 3 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 2 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Compositions and methods related to di-substituted bicyclo[2.2.1] heptanamine-containing compounds12 Dec 2023US 11,840,495 B2Instituto Carlos Slim De La Salud, A.C.
- Nitrogen-containing compound, electronic component and electronic device21 Mar 2023US 11,611,043 B1Shaanxi Lighte Optoelectronics Material Co., Ltd.
- Pleuromulin lauric acid ester with antibacterial activity and a method of preparing the same17 May 2022US 11,332,430 B1Xi'an Taikomed Pharmaceutical Technology Co., Ltd.
- Purification of pleuromutilin9 Feb 2021US 10,913,703 B2Nabriva Therapeutics AG
- Compound and organic electronic device using the same7 Jan 2020US 10,529,928 B2Shanghai Nichem Fine Chemical Co., Ltd.
- Compounds and methods to target glucose-stimulated phosphohistidine signaling and esophageal cancer growth28 Dec 2023US 2023/0416209 A1
- Compositions and methods related to di-substituted bicyclo[2.2.1] heptanamine-containing compounds4 Aug 2022US 2022/0242815 A1Instituto Carlos Slim De La Salud, A.C.
- Pleuromutilin derivatives for the treatment of diseases mediated by microbes14 Jul 2022US 2022/0218713 A1Nabriva Therapeutics AG
- Pleuromutilin derivatives for the treatment of diseases mediated by microbes22 Apr 2021US 2021/0113571 A1Nabriva Therapeutics AG
- Novel fully synthetic and semisynthetic pleuromutilin derivatives as new antibiotics and their preparation22 Apr 2021US 2021/0115003 A1Yale University
Most cited
By later US patents
- Method of producing ingenol-3-angelate8US 8,901,356 B2LEO Laboratories Limited · 2014
- Method of producing ingenol-3-angelate4US 9,416,084 B2LEO Laboratories Limited · 2016
- Method of producing ingenol-3-angelate4US 9,676,698 B2LEO Laboratories Limited · 2017
- Lube base oil and lubricating oil composition3US 7,964,540 B2Idemitsu Kosan Co., Ltd. · 2011
- Pleuromutilin derivatives having antibacterial activity2US 6,753,445 B2Biochemie Gesellschaft m.b.H. · 2004